These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37659201)

  • 1. HDAC11: A novel target for improved cancer therapy.
    Liu Y; Tong X; Hu W; Chen D
    Biomed Pharmacother; 2023 Oct; 166():115418. PubMed ID: 37659201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDAC11: a rising star in epigenetics.
    Liu SS; Wu F; Jin YM; Chang WQ; Xu TM
    Biomed Pharmacother; 2020 Nov; 131():110607. PubMed ID: 32841898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological function and small molecule inhibitors of histone deacetylase 11.
    Jia G; Liu J; Hou X; Jiang Y; Li X
    Eur J Med Chem; 2024 Oct; 276():116634. PubMed ID: 38972077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of HDAC11 in obesity-related metabolic disorders: A critical review.
    Yang H; Chen L; Sun Q; Yao F; Muhammad S; Sun C
    J Cell Physiol; 2021 Aug; 236(8):5582-5591. PubMed ID: 33481312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling HDAC11: Epigenetic orchestra in different diseases and structural insights for inhibitor design.
    Khatun S; Prasad Bhagat R; Dutta R; Datta A; Jaiswal A; Halder S; Jha T; Amin SA; Gayen S
    Biochem Pharmacol; 2024 Jul; 225():116312. PubMed ID: 38788962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDAC11 inhibition disrupts porcine oocyte meiosis via regulating α-tubulin acetylation and histone modifications.
    Huang R; Sui L; Fu C; Zhai Y; Dai X; Zhang S; Li Z
    Aging (Albany NY); 2021 Mar; 13(6):8849-8864. PubMed ID: 33742608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone Deacetylase 11 Is an ε-N-Myristoyllysine Hydrolase.
    Moreno-Yruela C; Galleano I; Madsen AS; Olsen CA
    Cell Chem Biol; 2018 Jul; 25(7):849-856.e8. PubMed ID: 29731425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDAC11 is a regulator of diverse immune functions.
    Yanginlar C; Logie C
    Biochim Biophys Acta Gene Regul Mech; 2018 Jan; 1861(1):54-59. PubMed ID: 29222071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDAC11 is a novel drug target in carcinomas.
    Deubzer HE; Schier MC; Oehme I; Lodrini M; Haendler B; Sommer A; Witt O
    Int J Cancer; 2013 May; 132(9):2200-8. PubMed ID: 23024001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Pharmacochemical Characterization Discover a Novel Brain-Permeable HDAC11-Selective Inhibitor with Therapeutic Potential by Regulating Neuroinflammation in Mice.
    Bai P; Liu Y; Yang L; Ding W; Mondal P; Sang N; Liu G; Lu X; Ho TT; Zhou Y; Wu R; Birar VC; Wilks MQ; Tanzi RE; Lin H; Zhang C; Li W; Shen S; Wang C
    J Med Chem; 2023 Dec; 66(23):16075-16090. PubMed ID: 37972387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDAC11: a multifaceted histone deacetylase with proficient fatty deacylase activity and its roles in physiological processes.
    Núñez-Álvarez Y; Suelves M
    FEBS J; 2022 May; 289(10):2771-2792. PubMed ID: 33891374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDAC11 promotes meiotic apparatus assembly during mouse oocyte maturation via decreasing H4K16 and α-tubulin acetylation.
    Sui L; Zhang S; Huang R; Li Z
    Cell Cycle; 2020 Feb; 19(3):354-362. PubMed ID: 31910069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic therapy of cancer with histone deacetylase inhibitors.
    Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
    J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase 11 suppresses p53 expression in pituitary tumor cells.
    Wang W; Fu L; Li S; Xu Z; Li X
    Cell Biol Int; 2017 Dec; 41(12):1290-1295. PubMed ID: 28782861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel HDAC11 inhibitors suppress lung adenocarcinoma stem cell self-renewal and overcome drug resistance by suppressing Sox2.
    Bora-Singhal N; Mohankumar D; Saha B; Colin CM; Lee JY; Martin MW; Zheng X; Coppola D; Chellappan S
    Sci Rep; 2020 Mar; 10(1):4722. PubMed ID: 32170113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma cell dependence on histone/protein deacetylase 11 reveals a therapeutic target in multiple myeloma.
    Mostofa A; Distler A; Meads MB; Sahakian E; Powers JJ; Achille A; Noyes D; Wright G; Fang B; Izumi V; Koomen J; Rampakrishnan R; Nguyen TP; De Avila G; Silva AS; Sudalagunta P; Canevarolo RR; Siqueira Silva MDC; Alugubelli RR; Dai HA; Kulkarni A; Dalton WS; Hampton OA; Welsh EA; Teer JK; Tungesvik A; Wright KL; Pinilla-Ibarz J; Sotomayor EM; Shain KH; Brayer J
    JCI Insight; 2021 Dec; 6(24):. PubMed ID: 34793338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylases: a saga of perturbed acetylation homeostasis in cancer.
    Parbin S; Kar S; Shilpi A; Sengupta D; Deb M; Rath SK; Patra SK
    J Histochem Cytochem; 2014 Jan; 62(1):11-33. PubMed ID: 24051359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDAC11 Regulates Glycolysis through the LKB1/AMPK Signaling Pathway to Maintain Hepatocellular Carcinoma Stemness.
    Bi L; Ren Y; Feng M; Meng P; Wang Q; Chen W; Jiao Q; Wang Y; Du L; Zhou F; Jiang Y; Chen F; Wang C; Tang B; Wang Y
    Cancer Res; 2021 Apr; 81(8):2015-2028. PubMed ID: 33602787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of AlphaFold models for drug discovery: Feasibility and challenges. Histone deacetylase 11 as a case study.
    Baselious F; Robaa D; Sippl W
    Comput Biol Med; 2023 Dec; 167():107700. PubMed ID: 37972533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone/protein deacetylase 11 targeting promotes Foxp3+ Treg function.
    Huang J; Wang L; Dahiya S; Beier UH; Han R; Samanta A; Bergman J; Sotomayor EM; Seto E; Kozikowski AP; Hancock WW
    Sci Rep; 2017 Aug; 7(1):8626. PubMed ID: 28819166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.